MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 269 filers reported holding MYRIAD GENETICS INC in Q3 2013. The put-call ratio across all filers is 2.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $476,000 | +74.4% | 14,351 | +8.3% | 0.01% | +25.0% |
| Q3 2016 | $273,000 | -36.5% | 13,256 | +19.9% | 0.01% | -46.7% |
| Q2 2014 | $430,000 | +13.8% | 11,054 | -31.3% | 0.02% | -6.2% |
| Q3 2013 | $378,000 | -16.9% | 16,088 | -5.0% | 0.02% | -23.8% |
| Q2 2013 | $455,000 | – | 16,942 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,750,000 | $75,900,000 | 2.61% |
| PFM Health Sciences, LP | 2,025,681 | $55,909,000 | 1.90% |
| Tieton Capital Management, LLC | 118,456 | $3,269,000 | 1.83% |
| Altium Capital Management LP | 190,000 | $5,244,000 | 1.45% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,846,490 | $50,963,000 | 1.03% |
| EARNEST PARTNERS LLC | 6,316,365 | $174,332,000 | 1.01% |
| Glenview Capital Management | 1,679,747 | $46,361,000 | 0.99% |
| Zebra Capital Management LLC | 14,209 | $392,000 | 0.63% |
| AIMZ Investment Advisors, LLC | 44,185 | $1,220,000 | 0.48% |
| Phocas Financial Corp. | 132,101 | $3,646,000 | 0.46% |